SANSTEMZA VANDEFITEMCEL Trademark

Trademark Overview


On Monday, August 3, 2020, a trademark application was filed for SANSTEMZA VANDEFITEMCEL with the United States Patent and Trademark Office. The USPTO has given the SANSTEMZA VANDEFITEMCEL trademark a serial number of 79295157. The federal status of this trademark filing is REGISTERED as of Tuesday, May 3, 2022. This trademark is owned by SanBio Company Limited. The SANSTEMZA VANDEFITEMCEL trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Stem cells for medical and veterinary purposes; pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of traumatic brain injury, cerebral infarction, cerebral hemorrhage, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury, and Alzheimer's disease; all the aforementioned being vandefitemcel that are stem cells affecting fibroblasts for use during cell therapy

Apparatus for the regeneration of stem cells for medical purposes; medical apparatus and instruments used for cell culture, namely, for cell culture chambers; medical apparatus and instruments, namely, cell testing apparatus in the nature of medical diagnostic apparatus for testing cancer cells, DNA, blood cells and extra cellular contents; medical apparatus and instruments, namely, intracellular material injector for medical purposes in the nature of injection instrument with needles, needle-based and needle-free injection systems; medical apparatus and instruments for monitoring vital signs, for use in orthopedic surgery; medical apparatus and instruments for analyzing substances for medical purposes, namely, blood and cell analyzers for medical diagnostics; medical apparatus and instruments, namely, test tubes for cell separation for medical purposes in the nature of blood testing apparatus, namely, blood sampling tubes; medical apparatus and instruments, namely, apparatus for the r...
sanstemza vandefitemcel

General Information


Serial Number79295157
Word MarkSANSTEMZA VANDEFITEMCEL
Filing DateMonday, August 3, 2020
Status700 - REGISTERED
Status DateTuesday, May 3, 2022
Registration Number6714879
Registration DateTuesday, May 3, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 15, 2022

Trademark Statements


Description of MarkThe mark consists of a blue wording "SANSTEMZA" below two blue and yellow rainbows and above the yellow wording "VANDEFITEMCEL". The white background is not claimed as a feature of the mark.
Goods and ServicesStem cells for medical and veterinary purposes; pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of traumatic brain injury, cerebral infarction, cerebral hemorrhage, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury, and Alzheimer's disease; all the aforementioned being vandefitemcel that are stem cells affecting fibroblasts for use during cell therapy
Indication of Colors claimedThe color(s) blue and yellow is/are claimed as a feature of the mark.
Translation of Words in MarkThe wording "SANSTEMZA" has no meaning in a foreign language.
Goods and ServicesApparatus for the regeneration of stem cells for medical purposes; medical apparatus and instruments used for cell culture, namely, for cell culture chambers; medical apparatus and instruments, namely, cell testing apparatus in the nature of medical diagnostic apparatus for testing cancer cells, DNA, blood cells and extra cellular contents; medical apparatus and instruments, namely, intracellular material injector for medical purposes in the nature of injection instrument with needles, needle-based and needle-free injection systems; medical apparatus and instruments for monitoring vital signs, for use in orthopedic surgery; medical apparatus and instruments for analyzing substances for medical purposes, namely, blood and cell analyzers for medical diagnostics; medical apparatus and instruments, namely, test tubes for cell separation for medical purposes in the nature of blood testing apparatus, namely, blood sampling tubes; medical apparatus and instruments, namely, apparatus for the regeneration of stem cells for medical purposes; gene and genetic testing apparatus in the nature of apparatus for DNA and RNA testing for medical purposes; medical apparatus and instruments, namely, cell injector for medical purposes in the nature of injection instrument with needles; medical apparatus and instruments, namely, needle-based and needle-free injection systems; implants consisting of artificial materials; artificial implants in the nature of surgical implants comprised of artificial materials and artificial vascular grafts
Disclaimer with Predetermined Text"VANDEFITEMCEL"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 13, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, October 13, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSanBio Company Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameSanBio Company Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameSanBio Company Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Monday, September 26, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, September 2, 2022FINAL DISPOSITION NOTICE SENT TO IB
Friday, September 2, 2022FINAL DISPOSITION PROCESSED
Friday, September 2, 2022LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Monday, August 15, 2022LIMITATION OF GOODS RECEIVED FROM IB
Wednesday, August 3, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 3, 2022REGISTERED-PRINCIPAL REGISTER
Saturday, March 26, 2022NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, March 9, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 9, 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sunday, February 20, 2022NOTIFICATION PROCESSED BY IB
Tuesday, February 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 15, 2022PUBLISHED FOR OPPOSITION
Wednesday, January 26, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 26, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 5, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 5, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 5, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, August 15, 2021REFUSAL PROCESSED BY IB
Monday, July 12, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 12, 2021NON-FINAL ACTION E-MAILED
Monday, July 12, 2021NON-FINAL ACTION WRITTEN
Wednesday, June 16, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 16, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 16, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 4, 2021REFUSAL PROCESSED BY IB
Wednesday, December 16, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, December 16, 2020REFUSAL PROCESSED BY MPU
Thursday, December 3, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, December 2, 2020NON-FINAL ACTION WRITTEN
Tuesday, November 24, 2020ASSIGNED TO EXAMINER
Saturday, October 17, 2020APPLICATION FILING RECEIPT MAILED
Tuesday, October 13, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 8, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB